methylene blue has been researched along with Left Ventricular Hypertrophy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, X; Kedem, J; Roitstein, A; Scholz, PM; Tse, J; Weiss, HR | 1 |
Leone, RJ; Scholz, PM; Weiss, HR | 1 |
Leone, RJ; Naim, KL; Rabindranauth, P; Scholz, PM; Tse, J; Weiss, HR | 1 |
Huang, MW; Leone, RJ; Scholz, PM; Tse, J; Weiss, HR | 1 |
4 other study(ies) available for methylene blue and Left Ventricular Hypertrophy
Article | Year |
---|---|
Effect of cyclic GMP reduction on regional myocardial mechanics and metabolism in experimental left ventricular hypertrophy.
Topics: Animals; Cyclic GMP; Dogs; Hypertrophy, Left Ventricular; Methylene Blue; Myocardial Contraction; Myocardium; Oxygen Consumption | 1996 |
Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.
Topics: Animals; Cyclic AMP; Cyclic GMP; Dogs; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart; Hemodynamics; Hypertrophy, Left Ventricular; Methylene Blue; Milrinone; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones; Reference Values | 1998 |
Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts.
Topics: Animals; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dogs; Enzyme Inhibitors; Guanylate Cyclase; Heart; Hypertrophy, Left Ventricular; In Vitro Techniques; Isoproterenol; Methylene Blue; Myocardium; Oxygen Consumption | 1998 |
Pacing-induced cardiac failure of hypertrophic hearts: effects of cyclic GMP reduction.
Topics: Animals; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Hypertrophy, Left Ventricular; Methylene Blue; Myocardial Contraction; Myocardium; Reference Values | 1999 |